Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Douglas Research Advisory

Equity Capital Markets

<ul>
<li>Nota's IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.</li>
<li>Our base case valuation of Nota suggests target price of 11,948 won per share, which is 31% higher than the IPO price (9,100 won). </li>
<li>Nota Provides technology that enables the efficient operation of high-performance AI models even on resource-constrained edge devices, centered around its proprietary AI model optimization platform, NetsPresso®.</li>
</ul>


Nota's IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.
Our base case valuation of Nota suggests target price of 11,948 won per share, which is 31% higher than the IPO price (9,100 won). 
Nota Provides technology that enables the efficient operation of high-performance AI models even on resource-constrained edge devices, centered around its proprietary AI model optimization platform, NetsPresso®.


Event-Driven

<ul>
<li>Palliser Capital started to go activist on LG Chem.  According to Palliser Capital, LG Chem's share price is trading at a 74% discount to its NAV.</li>
<li>Palliser Capital proposed improving the composition of the board of directors, restructuring the executive compensation system to align with shareholder interests, and higher share buybacks. </li>
<li>Our updated NAV analysis of LG Chem suggests implied price of 613,438 won per share, which represents a 57% higher levels than current levels.</li>
</ul>


Palliser Capital started to go activist on LG Chem.  According to Palliser Capital, LG Chem's share price is trading at a 74% discount to its NAV.
Palliser Capital proposed improving the composition of the board of directors, restructuring the executive compensation system to align with shareholder interests, and higher share buybacks. 
Our updated NAV analysis of LG Chem suggests implied price of 613,438 won per share, which represents a 57% higher levels than current levels.


Palliser Capital Goes Activist on LG Chem

Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of KRX stocks as of Oct 17th. The aggregated short interest was USD11.9bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in KorZinc, Samsung Electronics, ECOPRO, SK Hynix, ECOPROBM.</li>
</ul>


We analyzed the changes in short interest of KRX stocks as of Oct 17th. The aggregated short interest was USD11.9bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in KorZinc, Samsung Electronics, ECOPRO, SK Hynix, ECOPROBM.


KRX Short Interest Weekly (Oct 17th): KorZinc, Samsung Electronics, ECOPRO, SK Hynix, ECOPROBM

Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

Equity Bottom-Up

<ul>
<li>GRAIL Inc., a healthcare company whose mission is to detect cancer early when it can be cured, announced detailed results from its registrational PATHFINDER 2 study.</li>
<li>Samsung C&amp;T and Samsung Electronics also made a ~$110M equity investment in GRAIL at a price of $70.05 per share of common stock.</li>
<li>I expect GRAIL shares to outperform the market as solid performance from its Galleri test continues and investors are confident that the first MCED test will receive FDA approval.</li>
</ul>


GRAIL Inc., a healthcare company whose mission is to detect cancer early when it can be cured, announced detailed results from its registrational PATHFINDER 2 study.
Samsung C&amp;T and Samsung Electronics also made a ~$110M equity investment in GRAIL at a price of $70.05 per share of common stock.
I expect GRAIL shares to outperform the market as solid performance from its Galleri test continues and investors are confident that the first MCED test will receive FDA approval.


GRAIL: PATHFINDER 2 Results Were Impressive, Samsung C&T/Samsung Electronics Made Equity Investment

Quantitative Researcher, MRM Research

Nico Rosti

Quantitative Researcher

MRM Research

Quantitative Research

Equity Derivatives

<ul>
<li>A look at our probabilistic tactical models for US and Asian Equities: comparing which stocks are overbought and which ones are oversold.</li>
<li>Between the US Stocks we track, all seems to have room to rally, short-term, and <a href="https://www.smartkarma.com/entities/amazon-com-inc" target="_blank" data-smartkarma-citation="entities:409:1" rel="noopener">Amazon (AMZN US)</a> is actually <strong>oversold (buy opportunity)</strong>. </li>
<li>The Asian Stocks we track instead show a less homogeneous picture, but <strong>several Asian stocks are incredibly overbought. Same as Gold. </strong>
</li>
</ul>


A look at our probabilistic tactical models for US and Asian Equities: comparing which stocks are overbought and which ones are oversold.
Between the US Stocks we track, all seems to have room to rally, short-term, and Amazon (AMZN US) is actually oversold (buy opportunity). 
The Asian Stocks we track instead show a less homogeneous picture, but several Asian stocks are incredibly overbought. Same as Gold. 



Cross-Market Outlook: US Vs Asia — Who’s Overbought, Who’s Oversold?

South Korea

Samsung Electronics Co., Ltd. manufactures a wide range of consumer and industrial electronic equipment and products such as semiconductors, personal computers, peripherals, monitors, televisions, and home appliances including air conditioners and microwave ovens. The Company also produces Internet access network systems and telecommunications equipment including mobile phones.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Samsung Electronics (005930 KS)

Nota IPO Bookbuilding Analysis

Nota's IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.

Douglas Kim

Palliser Capital Goes Activist on LG Chem

Palliser Capital started to go activist on LG Chem. According to Palliser Capital, LG Chem's share price is trading at a 74% discount to its NAV.

Douglas Kim

KRX Short Interest Weekly (Oct 17th): KorZinc, Samsung Electronics, ECOPRO, SK Hynix, ECOPROBM

We analyzed KRX short interest report for the past week and highlighted short interest changes in KorZinc, Samsung Electronics, ECOPRO, SK Hynix,...

Ke Yan, CFA, FRM

GRAIL: PATHFINDER 2 Results Were Impressive, Samsung C&T/Samsung Electronics Made Equity Investment

Healthcare company GRAIL Inc. released impressive results from PATHFINDER 2 study. In my insight, I discuss key highlights of the study, private...

Andrei Zakharov

Cross-Market Outlook: US Vs Asia — Who’s Overbought, Who’s Oversold?

Probabilistic tactical models show Asian stocks and Gold are incredibly overbought if compared to US stocks: the latter have still room to rally...

Nico Rosti

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Nota IPO Bookbuilding Analysis

Nota's IPO price has been confirmed at 9,100 won, which is at the high end of the IPO price range. The demand ratio was 1,058 to 1.

Douglas Kim

Palliser Capital Goes Activist on LG Chem

Palliser Capital started to go activist on LG Chem. According to Palliser Capital, LG Chem's share price is trading at a 74% discount to its NAV.

Douglas Kim

KRX Short Interest Weekly (Oct 17th): KorZinc, Samsung Electronics, ECOPRO, SK Hynix, ECOPROBM

We analyzed KRX short interest report for the past week and highlighted short interest changes in KorZinc, Samsung Electronics, ECOPRO, SK Hynix,...

Ke Yan, CFA, FRM

GRAIL: PATHFINDER 2 Results Were Impressive, Samsung C&T/Samsung Electronics Made Equity Investment

​Healthcare company GRAIL Inc. released impressive results from PATHFINDER 2 study. In my insight, I discuss key highlights of the study, private...

Andrei Zakharov

Cross-Market Outlook: US Vs Asia — Who’s Overbought, Who’s Oversold?

​Probabilistic tactical models show Asian stocks and Gold are incredibly overbought if compared to US stocks: the latter have still room to rally...

Nico Rosti

Healthcare company GRAIL Inc. released impressive results from PATHFINDER 2 study. In my insight, I discuss key highlights of the study, private...

Probabilistic tactical models show Asian stocks and Gold are incredibly overbought if compared to US stocks: the latter have still room to rally...